F. Tsang

Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma.

J. Luk, P. Day, L. Beretta, 2009, Journal of proteome research.

Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma

J. Luk, S. Fan, F. Kolligs, 2012, Oncogene.

Prognostic significance and therapeutic potential of eukaryotic translation initiation factor 5A (eIF5A) in hepatocellular carcinoma

Chunsheng Zhang, H. Dai, J. Luk, 2010, International journal of cancer.

Prognostic Marker MicroRNA-125b Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells Via Suppressing Tumorigenic Molecule eIF5A2

Angela M. Liu, J. Luk, S. Fan, 2014, Digestive Diseases and Sciences.

Expression of ankyrin repeat and SOCS box containing 4 (ASB4) confers migration and invasion properties of hepatocellular carcinoma cells.

S. Fan, R. Poon, K. Man, 2014, Bioscience trends.

The use of small peptides in the diagnosis and treatment of hepatocellular carcinoma.

J. Luk, N. P. Lee, F. Tsang, 2009, Protein and peptide letters.